Propanc Biopharma, a Nasdaq-listed biotech firm, has secured up to $100 million to bolster its digital asset strategy.
Related Posts
Expert says US may hit Binance with criminal indictment
John Reed Stark, president of John Reed Stark Consulting and former SEC Enforcement Division member speculates on the…
Dogwifhat ‘needs to see vet’ after facing steep price drop, analyst says
Dogwifhat, despite a price drop, saw trading volume increase by more than 51%, settling at $1.1 billion after…
French police bust $1.8M crypto villa scam targeting wealthy couple
French police have arrested two suspected fraudsters accused of stealing about $1.8 million in cryptoassets from a wealthy…